36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Global health governance structures today are failing to address the global health crises of both communicable and non-communicable diseases. This failure is driven by the trend of a market justice approach to health and a lack of global health leadership. Kiddell-Monroe demonstrates how these trends impacted the negotiation of global intellectual property regulations and debates on access to NCD medicines in favour of private over public interest. She concludes that this trend raises three central challenges for global health: (i) addressing broad participation, (ii) the dilution of the…mehr

Produktbeschreibung
Global health governance structures today are failing to address the global health crises of both communicable and non-communicable diseases. This failure is driven by the trend of a market justice approach to health and a lack of global health leadership. Kiddell-Monroe demonstrates how these trends impacted the negotiation of global intellectual property regulations and debates on access to NCD medicines in favour of private over public interest. She concludes that this trend raises three central challenges for global health: (i) addressing broad participation, (ii) the dilution of the meaning of global health, and (iii) the co-optation of the global health agenda by corporate interests. Using nodal and constitutional theory, Kiddell-Monroe proposes a multicentric global governance for health model that can directly address the trends and their global health related challenges. The multicentric model offers a framework in which WHO, States and non-State actors can collectively govern global health so as to truly promote equity and social justice.
Autorenporträt
Rachel Kiddell-Monroe is a lawyer and activist specialising in humanitarian assistance, access to medicines, global health, governance and bioethics. She is a Professor of Practice at McGill University, lectures on international development and is on the International Board of the Nobel Prize winning medical aid agency, Médecins Sans Frontières.